RDIF will deliver 100 million doses of vaccine from COVID-19 to India

On September 16, 2020 the Russian Direct Investment Fund (RDIF) announced signing of the contract on delivery of 100 million doses of vaccine from COVID-19 to India. The agreement is signed with pharmaceutical company Dr. Reddy's Laboratories Ltd (Dr. Reddy’s).

The medicine "Sputnik of V" will be directed to India after obtaining results of clinical trials and registration of vaccine. To India will send 100 million doses of vaccine, deliveries should begin at the end of 2020.

As noted in RDIF, the agreement with Dr. Reddy’s shows increase in number of the states and organizations which understand importance of diversified approach to portfolio construction of vaccines for protection of the population against a coronavirus.

RDIF will deliver 100 million doses of vaccine against a coronavirus to India

India is among the countries, the most seriously injured from a coronavirus, and we consider that our platform on the basis of two adenoviral vectors of the person will provide to India the safe and scientifically confirmed tool for fight against a coronavirus — the CEO of RDIF Kirill Dmitriyev said.

The cochairman of Board of Directors and the managing director of Dr. Reddy's G.V. Prasad greeted carrying out in India the third phase of tests of vaccine and hoped that she will help to struggle with a coronavirus in the country.

Professor of faculty of fundamental medicine of Lomonosov Moscow State University, the deputy chief physician for anesthesiology and resuscitation of hospital No. 52 of Moscow Sergey Tsarenko says that at the vaccine "Sputnik of V" safety is ensured by use of vectors of adenovirus of the person which we repeatedly meet throughout the life. The efficiency is reached by consecutive use of two different adenoviruses of the person - it is the solution which selects vaccine among competitors, he noted (words are cited on the website of RDIF).^[1]

Notes